G2 Intelligence
VerifiedOnline/Digital
G2 Intelligence provides timely, accurate and trusted analysis of industry and market trends, legal and regulatory developments, and technology and innovation that directly affect the operations, financial performance, and competitive position of diagnostic testing laboratories and related medical services providers.
The company has covered and reported on the diagnostic industry for over 30 years. G2 Intelligence delivers topical and analytical periodicals, proprietary research studies, and custom advisory services, and through live and virtual events, facilitates industry meetings and information exchanges.
Our mission is to deliver relevant, meaningful and actionable findings on diagnostic industry markets, related regulatory changes, and lab operations. The organization strives to exceed client expectations and develop mutually beneficial relationships with industry leaders and influencers.
G2 Intelligence is a division of Plain Language Media, LLLP, a leading provider of a multimedia specialty information publications. Source
Actions
Media Outlet details
| Scope | Trade/B2B |
|---|---|
| Language | English |
| Country | United States of America |
|
Similarweb UVM |
Request pricing |
|
Comscore UVM |
Request pricing |
Recent Articles
Search ArticlesCarbon Impact Report Shows Growing Lab Commitment to Reducing Carbon Emissions
Life sciences and clinical laboratories are accelerating zero-carbon goals, says My Green Lab CEO
Diagnostics Pipeline: Xella Health Launches Platform Focused on Women’s Medical Issues
The startup is trying to close the care gap between female and male patients
CAP Updates Guideline to Reduce Diagnostic Errors Through Structured Case Reviews
Start a Free Trial for immediate access to this article
Lessons in Laboratory Compliance from a $30 Million Settlement
‘Lean lab’ setup appears to have caught the eyes of investigators
Dx Deals: Labcorp Quietly Buys Tribal Diagnostics
Start a Free Trial for immediate access to this article
FDA Watch: Zepto Life Technology Receives FDA Breakthrough Designation for Blood-Based Mold Test
Its FungiFlex assay can make determining the cause of fungal infections vastly more accurate
How to Effectively Manage Indoor Air Quality in Clinical Labs
These core steps are fundamental for protecting laboratory workers from airborne contamination
Clarisa Blattner: Could Medicare LCD Policy Be Poised for Reform?
Home 5 News 5 Clarisa Blattner: Could Medicare LCD Policy Be Poised for Reform? Details behind the proposed Timely Access to Coverage Decisions Act Credit: LabX Media Group (photo courtesy of XiFin) As diagnostic innovation continues to accelerate, one factor increasingly determines whether patients ultimately benefit from new technologies: coverage.
Growing Need for Companion Diagnostics is Evident at Drug Discovery Event
The momentum for targeted therapies has downstream implications for clinical laboratories
What the $1b Roche-PathAI Deal Can Tell Clinical Lab Directors
Start a Free Trial for immediate access to this article